Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial

This publication has 16 references indexed in Scilit:

• Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a [see comments]
  Blood, 1990
• ANTIBODIES TO LYMPHOBLASTOID INTERFERON
  The Lancet, 1989
• Recombinant human interferon (IFN) alpha‐2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti‐interferon antibodies
  British Journal of Haematology, 1989
• Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies
  New England Journal of Medicine, 1988
• CLINICAL SIGNIFICANCE OF ANTI-IFN-α ANTIBODY TITRES DURING INTERFERON THERAPY
  The Lancet, 1987
• Interferon treatment of renal cell carcinoma. Current status and future prospects
  Cancer, 1987
• Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection
  Cancer, 1987
• Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (intron a)
  The American Journal of Medicine, 1986
• ANTIBODIES TO HUMAN LEUCOCYTE INTERFERONS IN CANCER PATIENTS
  The Lancet, 1983
• Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon
  Nature, 1981